Drug-Induced Insomnia: Descriptive analysis of FDA Adverse Event Reporting System. Asian Journal of Pharmaceutics (AJP), [S. l.], v. 16, n. 3, 2022. DOI: 10.22377/ajp.v16i3.4489. Disponível em: https://www.asiapharmaceutics.info/index.php/ajp/article/view/4489. Acesso em: 15 apr. 2026.